Table 1 Clinical information for the H-JNK1 and L-JNK1 HCC patients
From: JNK1 activation predicts the prognostic outcome of the human hepatocellular carcinoma
|  | H-JNK1 n = 17 | L-JNK1 n = 14 | p – value |
|---|---|---|---|
Sex (M/F) | 13/4 | 10/4 | 0.5616 |
Age, y (range) | 55.6 (32–70) | 52.3 (42–69) | 0.4110 |
HBV | 13 | 9 | 0.4903 |
HCV | nd* | nd | Â |
Cirrhosis | 5 | 9 | 0.1936 |
Encapsulation | 5 | 9 | 0.1936 |
AFP (+/-) | 12/5 | 9/5 | 0.5486 |
   > 200 | 9 | 5 | 0.3971 |
   > 400 | 8 | 3 | 0.2507 |
Tumor grade (II/III) | 7/10 | 9/5 | 0.3401 |
Tumor diameter (cm) | 7.3 ± 2.8 | 5.0 ± 2.7 | 0.0270 |
Survival (months) | 21.7 ± 19** | 39.1 ± 30 | 0.073 |
   Male | 14 ± 14 | 42 ± 30 | 0.0120 |
   Female | 43 ± 14 | 28 ± 34 | 0.459 |